vimarsana.com
Home
Live Updates
Lunaphore and Abcam Announce Agreement for Primary Antibody
Lunaphore and Abcam Announce Agreement for Primary Antibody
Lunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET, Combining Power of Trusted Antibody Provider With Superior Multiplex Capabilities
Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and abcam (NASDAQ: ABCM), a global life science company working together with researchers
Related Keywords
United States ,
Switzerland ,
American ,
Swiss ,
Irene Tamayo ,
Courtney Nicholson ,
Abcam Corporate Communications ,
Application Development Team Leader ,
Lunaphore Corporate Communications ,
American Association For Cancer Research ,
Nasdaq ,
Business Development ,
Chief Marketing Officer ,
Vice President Business Development ,
American Association ,
Cancer Research ,
Annual Meeting ,
Corporate Communications ,
Lunaphore ,
Webcam ,
Nnounce ,
Agreement ,
Primary ,
Ntibody ,
Validation ,
Comet ,
Combining ,
Tower ,
Rusted ,
Provider ,
Ith ,
Superior ,
Multiplex ,
Capabilities ,